- Home
- DNTH vs MSC Comparison
DNTH vs MSC Comparison
Compare DNTH & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MSC
- Stock Information
- Founded
- DNTH 2015
- MSC 2000
- Country
- DNTH United States
- MSC Hong Kong
- Employees
- DNTH N/A
- MSC N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MSC Hotels/Resorts
- Sector
- DNTH Health Care
- MSC Consumer Discretionary
- Exchange
- DNTH Nasdaq
- MSC Nasdaq
- Market Cap
- DNTH 657.0M
- MSC 572.0M
- IPO Year
- DNTH N/A
- MSC 2018
- Fundamental
- Price
- DNTH $17.39
- MSC $2.86
- Analyst Decision
- DNTH Strong Buy
- MSC
- Analyst Count
- DNTH 8
- MSC 0
- Target Price
- DNTH $53.00
- MSC N/A
- AVG Volume (30 Days)
- DNTH 255.5K
- MSC 5.4K
- Earning Date
- DNTH 05-12-2025
- MSC 05-08-2025
- Dividend Yield
- DNTH N/A
- MSC N/A
- EPS Growth
- DNTH N/A
- MSC N/A
- EPS
- DNTH N/A
- MSC N/A
- Revenue
- DNTH $6,524,000.00
- MSC $650,708,000.00
- Revenue This Year
- DNTH N/A
- MSC $8.92
- Revenue Next Year
- DNTH N/A
- MSC N/A
- P/E Ratio
- DNTH N/A
- MSC N/A
- Revenue Growth
- DNTH 102.36
- MSC 19.57
- 52 Week Low
- DNTH $13.37
- MSC $2.30
- 52 Week High
- DNTH $32.27
- MSC $9.30
- Technical
- Relative Strength Index (RSI)
- DNTH 35.86
- MSC 41.75
- Support Level
- DNTH $17.40
- MSC $2.83
- Resistance Level
- DNTH $18.45
- MSC $2.90
- Average True Range (ATR)
- DNTH 1.21
- MSC 0.12
- MACD
- DNTH -0.22
- MSC -0.01
- Stochastic Oscillator
- DNTH 10.60
- MSC 3.47
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.